Matthew A. Jefferson, MS, PhD

Payer & HEOR MSL
argenx

Poster(s):

• (288) Indirect treatment comparison of efgartigimod vs immunoglobulins in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  Wednesday, October 29, 2025